SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SANGUINE CORP. (SGNC)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Profiteer who wrote (1004)6/17/1998 12:44:00 PM
From: Gwolf   of 5402
 
Dixie 7777, In regards to your PM to me yes the true revenues are $952 per in my evaluation on post 766. I stated them as $95 per share for 2 reasons. (1) to see if anybody would actually work through the math.
(2) If I put a potential market value of $850 a share the world would have a heart attack just reading it. You can see why I have stated that at $1 the reward to risk ratio is without question in your favor as an investor. I have grossly understated the value of this stock on purpose. I am glad to see that somebody finally caught this.

Gwolf
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext